These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 185491)

  • 1. Semisynthetic glucagon derivatives for structure-function studies.
    Hruby VJ; Wright DE; Lin MC; Rodbell M
    Metabolism; 1976 Nov; 25(11 Suppl 1):1323-5. PubMed ID: 185491
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologic activity and conformational properties of glucagon and glucagon analogs.
    Epand RM; Cote TE; Hoa DH; Rosselin G; Schreier S
    Metabolism; 1976 Nov; 25(11 Suppl 1):1317-8. PubMed ID: 185490
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparation and properties of glucagon analogs prepared by semi-synthesis from CNBr-glucagon.
    Wright DE; Hruby VJ; Rodbell M
    Biochim Biophys Acta; 1980 Aug; 631(1):49-58. PubMed ID: 6249392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipolytic and adenyl-cyclase-stimulating activity of glucagon 1-6: comparison with glucagon derivatives chemically modified in the 7-29 sequence.
    Jean-Baptiste E; Rizack MA; Epand RM
    Biosci Rep; 1982 Oct; 2(10):819-24. PubMed ID: 7171745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semisynthetic D-His1,N epsilon-acetimidoglucagon: structure-function relationships.
    Mahrenholz AM; Flanders KC; Hoosein NM; Gurd FR; Gurd RS
    Arch Biochem Biophys; 1987 Sep; 257(2):379-86. PubMed ID: 2821912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay for the glucagon receptor.
    Rojas FJ; Birnbaumer L
    Methods Enzymol; 1985; 109():3-12. PubMed ID: 2985919
    [No Abstract]   [Full Text] [Related]  

  • 7. The glucagon receptor from liver can be functionally fused to caudate nucleus adenylate cyclase.
    Tolkovsky AM; Martin BR
    FEBS Lett; 1982 Dec; 150(2):337-42. PubMed ID: 6297980
    [No Abstract]   [Full Text] [Related]  

  • 8. Coupling of the glucagon receptor to adenylate cyclase.
    Houslay MD
    Biochem Soc Trans; 1979 Oct; 7(5):843-6. PubMed ID: 229036
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of nonspecific hydrophobic interactions in the biological activity of N epsilon-acyl derivatives of glucagon. Studies of conformation, receptor binding, and adenylate cyclase activation.
    Carrey EA; Epand RM
    J Biol Chem; 1982 Sep; 257(18):10624-30. PubMed ID: 6286664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of specific trinitrophenylation of the lysine epsilon amino group of glucagon on receptor binding and adenylate cyclase activation.
    Liepnieks JJ; Epand RM
    Arch Biochem Biophys; 1983 Aug; 225(1):102-9. PubMed ID: 6311099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor binding and adenylate cyclase activities of glucagon analogues modified in the N-terminal region.
    McKee RL; Pelton JT; Trivedi D; Johnson DG; Coy DH; Sueiras-Diaz J; Hruby VJ
    Biochemistry; 1986 Apr; 25(7):1650-6. PubMed ID: 3011069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of glucagon inactivation. Effect on glucagon--receptor interactions and glucagon-stimulated adenylate cyclase activity in liver cell membranes.
    Desbuquois B; Krug F; Cuatrecasas P
    Biochim Biophys Acta; 1974 Mar; 343(1):101-20. PubMed ID: 4364124
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure-function relationships in glucagon: properties of highly purified des-His-1-, monoiodo-, and (des-Asn-28, Thr-29)(homoserine lactone-27)-glucagon.
    Lin MC; Wright DE; Hruby VJ; Rodbell M
    Biochemistry; 1975 Apr; 14(8):1559-63. PubMed ID: 164891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exchange of partners in glucagon receptor-adenylate cyclase complexes. Physical evidence for the independent, mobile receptor model.
    Houslay MD; Ellory JC; Smith GA; Hesketh TR; Stein JM; Warren GB; Metcalfe JC
    Biochim Biophys Acta; 1977 Jun; 467(2):208-19. PubMed ID: 195604
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation of 2-thioltryptophan-glucagon and (tryptophan-S-glucagon)2. Differences in binding to the glucagon receptor in the hepatic adenylate cyclase system.
    Wright DE; Rodbell M
    J Biol Chem; 1980 Nov; 255(22):10884-7. PubMed ID: 7430160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (Des-histidine 1) (N epsilon-phenylthiocarbamoyllysine 12)-glucagon: effects on glycogenolysis in perfused rat liver.
    Khan BA; Bregman MD; Nugent CA; Hruby VJ; Brendel K
    Biochem Biophys Res Commun; 1980 Apr; 93(3):729-36. PubMed ID: 7387671
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions polypeptide hormones with cell membrane specific receptors: studies with insulin and glucagon.
    Freychet P
    Diabetologia; 1976 May; 12(2):83-100. PubMed ID: 178558
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluorescent glucagon derivatives. I. Synthesis and characterisation of fluorescent glucagon derivatives.
    Heithier H; Ward LD; Cantrill RC; Klein HW; Im MJ; Pollak G; Freeman B; Schiltz E; Peters R; Helmreich EJ
    Biochim Biophys Acta; 1988 Oct; 971(3):298-306. PubMed ID: 2844291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function relationships in glucagon. Re-evaluation of glucagon-(1-21).
    Frandsen EK; Thim L; Moody AJ; Markussen J
    J Biol Chem; 1985 Jun; 260(12):7581-4. PubMed ID: 2987259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of vinblastine on the glucagon, basal and GTP-stimulated states of the adenylate cyclase from rat liver plasma membranes.
    Whetton AD; Houslay MD
    FEBS Lett; 1980 Mar; 111(2):290-4. PubMed ID: 6244186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.